U.S., July 26 -- ClinicalTrials.gov registry received information related to the study (NCT07086300) titled 'Electroacupuncture Combined With PD-1 Inhibitor for Elderly Patients With Advanced NSCLC' on July 08.
Brief Summary: The goal of this clinical trial is to elucidate the clinical efficacy and safety of electroacupuncture combined with PD-1 inhibitor therapy in elderly patients with advanced non-small cell lung cancer (NSCLC) through a multicenter, randomized controlled clinical trial. The main question it aims to answer is: the combination of electroacupuncture and PD-1 inhibitor therapy has demonstrated significant improvements in both clinical efficacy and safety profiles among elderly patients with advanced NSCLC. Researchers will...